Translational Research in Ovarian Cancer

Maria Flavia Di Renzo; Giorgio Valabrega

doi:10.3390/cancers12123676

Translational Research in Ovarian Cancer

Maria Flavia Di Renzo, Giorgio Valabrega

Istituto Oncologico Candiolo

Research output: Contribution to journal › Article › peer-review

Abstract

Ovarian cancer is still the most lethal gynecologic malignancy with a median five-year survival of 48%, including the less malignant and early diagnosed cases [...].

Original language	English
Journal	Cancers
Volume	12
Issue number	12
DOIs	https://doi.org/10.3390/cancers12123676
Publication status	Published - Dec 8 2020

Access to Document

10.3390/cancers12123676

Cite this

@article{961e8252f48b4125aa9f4a336ebd7137,

title = "Translational Research in Ovarian Cancer",

abstract = "Ovarian cancer is still the most lethal gynecologic malignancy with a median five-year survival of 48%, including the less malignant and early diagnosed cases [...].",

author = "{Di Renzo}, {Maria Flavia} and Giorgio Valabrega",

year = "2020",

month = dec,

day = "8",

doi = "10.3390/cancers12123676",

language = "English",

volume = "12",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI AG",

number = "12",

}

TY - JOUR

T1 - Translational Research in Ovarian Cancer

AU - Di Renzo, Maria Flavia

AU - Valabrega, Giorgio

PY - 2020/12/8

Y1 - 2020/12/8

N2 - Ovarian cancer is still the most lethal gynecologic malignancy with a median five-year survival of 48%, including the less malignant and early diagnosed cases [...].

AB - Ovarian cancer is still the most lethal gynecologic malignancy with a median five-year survival of 48%, including the less malignant and early diagnosed cases [...].

U2 - 10.3390/cancers12123676

DO - 10.3390/cancers12123676

M3 - Article

C2 - 33302341

VL - 12

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 12

ER -

Translational Research in Ovarian Cancer

Abstract

Access to Document

Fingerprint

Cite this